Stem cell medicine gets a roadmap and a quality …

Credit: Samantha Morris, PhD, Boston Children's Hospital

As in this map on the cover of Cell, a cell has many possible destinations or fates, and can arrive at them through three main stem cell engineering methods:

reprogramming (dialing a specialized cell, such as a skin cell, back to a stem-like state with full tissue-making potential) differentiation (pushing a stem cell to become a particular cell type, such as a blood cell) direct conversion (changing one kind of specialized cell to another kind)

Freely available on the Internet, CellNet provides clues to which methods of cellular engineering are most effectiveand acts as a much-needed quality control tool.

To date, there has been no systematic means to determine how closely cells made in a petri dish approximate natural tissues in the body, says George Q. Daley, MD, PhD, director of the Stem Cell Transplantation Program at Boston Childrens Hospital, senior investigator on two studies published by Cell last week.

CellNet adds that analytical rigor and even suggests ways to make the cells better. As shown below, the algorithms inputs are engineered cells made through the different methods. The outputs are comparisons of these cells gene regulatory networks (which genes are turned on or off) to those of the real-life cells or tissues theyre meant to emulate. At far right, the algorithm flags potential genetic on/off switches that a scientist could target to improve upon his or her cells, then ranks them in order of priority.

Courtesy Patrick Cahan, PhD

CellNet will also be a powerful tool to advance synthetic biologyto engineer cells for specific medical applications, says James Collins, PhD, of the Wyss Institute for Biologically Inspired Engineering and Boston University, and co-senior author on the first study, which used CellNet to assess cells created in 56 published studies.

The second study delved into a recurring question in stem cell biology: Is it feasible to directly convert one specialized cell type to another, skipping the laborious process of making a stem cell?

Previously, most attempts to directly convert one specialized cell type to another have depended on a trial-and-error approach, notes Patrick Cahan, PhD, a Daley lab member and principal architect of CellNet.

Read more from the original source:
Stem cell medicine gets a roadmap and a quality ...